- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03940508
Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools
Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools: A Preliminary Study
Completing evidence-based treatments for depression has been shown to be particularly problematic for Black adolescents. If Black adolescents' depression treatment needs are to be met, the engagement challenges and the factors that lessen the success of treatment in the "real world" must be addressed. The investigators will examine the effectiveness of the Making Connections Intervention (MCI) and investigate key mediators of both engagement and response to treatment for depression. The MCI is a 1-2 session, evidence-based intervention designed to improve engagement, perceived relevance, and treatment satisfaction among depressed, Black adolescents. The study also uses tailored outreach strategies for adolescents and parents by including innovative digital content such as a web page/app along with other digital products.
This study will address an important public health issue: How best to connect Black adolescents with depression to treatment in clinically meaningful ways, and how best to deliver evidence-based treatment to them through school-based services.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Completing evidence-based treatments for depression has been shown to be particularly problematic for Black adolescents. Their rates of participation in treatments for depression are lower due to negative perceptions of services and providers, and their reluctance to acknowledge the presence of symptoms.
If Black adolescents' depression treatment needs are to be met, the engagement challenges and the factors that lessen the success of treatment in the "real world" must be addressed. This research examines the effectiveness of the Making Connections Intervention (MCI) and investigates key mediators of both engagement and response to treatment for depression. The MCI is a 1-2 session, evidence-based intervention designed to improve engagement, perceived relevance, and treatment satisfaction among depressed, Black adolescents. The study also uses tailored outreach strategies for adolescents and parents by including innovative digital content such as a web page/app along with other digital products.
The investigators previously performed a small pilot study that used the MCI as an add-on to the IPT-A, an evidence-based intervention for depression delivered in schools typically over 12 sessions. The results suggested that MCI has a positive impact on many aspects of change associated with treatment engagement and clinical outcomes.
This study will be a randomized controlled trial. It will examine the effectiveness of the MCI in a multi-school trial involving adolescents in grades 6-12 who attend New York City (NYC) Department of Education (DOE) Public Schools. The investigators will randomly assign 60 Black students with depression symptoms to two conditions: MCI+IPT-A vs. IPT-A-alone. The investigators will also do qualitative research, like interviews, before the digital content is created. This will enhance the relevance of the MCI. The main outcomes are adolescent-and caregiver-level engagement and adolescent depression. Suicidal ideation is a secondary outcome. This study will also test related factors, like adolescent helping-seeking behavior and parental knowledge of mental health services, that can account for treatment outcomes and that will allow the MCI to be strengthened in future roll-outs of the intervention in school settings.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael A Lindsey, PhD
- Phone Number: (212) 998-5927
- Email: michael.lindsey@nyu.edu
Study Contact Backup
- Name: Tracy M Grogan, MS
- Phone Number: (212) 992-6902
- Email: tmg374@nyu.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10003
- Not yet recruiting
- Columbia University
-
Contact:
- Laura Mufson, PhD
- Phone Number: 646-774-5791
- Email: Laura.Mufson@nyspi.columbia.edu
-
Sub-Investigator:
- Laura Mufson, PhD
-
New York, New York, United States, 10003
- Recruiting
- McSilver Institute for Poverty Policy and Research
-
Contact:
- Michael A Lindsey, PhD
- Phone Number: (212) 998-5927
- Email: michael.lindsey@nyu.edu
-
Contact:
- Tracy M Grogan, MS
- Phone Number: 212-992-6902
- Email: tmg374@nyu.edu
-
Principal Investigator:
- Michael A Lindsey, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must identify as Black and/or African American
- Must be enrolled in grades 6-12 (except 12th graders in their last semester)
- Must be able to speak English
- Must have received caregiver consent and have assented to participate
- Must meet depression and global functioning levels indicated by a CES-D score ≥16, a Hamilton Rating Scale of Depression (HRSD) Score ≥ 10, and a Global Assessment Scale for Children (C-GAS) score ≤ 65 at baseline
- Students who are currently on a stable dose of anti-depressant medication, but still meet inclusion criteria, can be enrolled in the study.
Exclusion Criteria:
- Actively suicidal with intent or plan
- Intellectually disabled
- Have a life threatening medical illness
- Have a current primary substance abuse diagnosis in the moderate to severe range, schizophrenia, bipolar disorder, any evidence of psychosis, a primary diagnosis of anorexia
- Currently in active treatment for depression (excluding medication) at baseline assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MCI + IPT-A
Participants will receive the Making Connections Intervention (MCI) in addition to IPT-A for depression.
|
The MCI is a one to two session intervention that addresses barriers to mental health treatment and helps adolescents build skills to get the most out of their treatment experience.
It is designed to be delivered by a trained clinician in conjunction with an evidence-based treatment.
IPT-A is a time-limited, manualized treatment for depression focused on maladaptive communication patterns and interpersonal interactions.
Other Names:
|
Active Comparator: IPT-A Only
Participants will receive IPT-A for depression.
|
IPT-A is a time-limited, manualized treatment for depression focused on maladaptive communication patterns and interpersonal interactions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Barriers for Adolescents Seeking Health (BASH)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
Self-report questionnaire that targets barriers to seeking professional psychological help
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Child Help-Seeking Scale (HSS)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
Self-report 28-item questionnaire designed to measure children's and adolescents' willingness to seek help for psychosocial problems from adults in the school setting.
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Attitudes Toward Psychological Help Scale (ATPHS)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
This scale assesses psychological factors, including stigma, perceived relevance of treatment, etc., that impact one's perceptions of and attitudes about using formal mental health treatment services.
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Stages of Change (SOC)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
32-item instrument for assessing the readiness for changes in relation to general problems, or problems associated with participation in psychotherapy.
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Penn Helping Alliance (Haq-R)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
This questionnaire collects data from both the therapist and patient to measure the strength of the bond between therapist and patient, called the "therapeutic alliance."
|
Baseline, week 1, weeks 4, 8, 12
|
MCI Integrity Scale (MCI)
Time Frame: Week 1
|
To measure treatment integrity in Making Connections Intervention (MCI)
|
Week 1
|
Change in IPT-A Fidelity Form (IPT-A)
Time Frame: From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
To measure treatment integrity in IPT-A and maintain treatment effectiveness
|
From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
Change in Barriers to Treatment Participation Scale (BTPS)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
To test whether perceived barriers to treatment influence dropping out and other measures of participation in treatment.
To assess a broad range of barriers evident over the course of treatment, including four thematic areas: stressors and obstacles that compete with treatment, treatment demands and issues, perceived relevance of treatment, and relationship with the therapist.
|
Baseline, week 1, weeks 4, 8, 12
|
Understanding Mood Disorders Questionnaire (UMDQ)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
Designed to measure family members' attributions about and knowledge of symptoms, course, and treatment of mood disorders
|
Baseline, week 1, weeks 4, 8, 12
|
Therapy Survey (TS)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
To measure change in expectations about treatment at a children's psychiatric clinic about a week before their first therapy and counseling sessions.
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Progress of Treatment (POT)
Time Frame: From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
To measure adolescent engagement in treatment in order to control for the common factors of psychotherapy.
|
From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
Change in Engagement Measure (EM)
Time Frame: Week 8 and Week 12
|
An 11-item measures for engagement, which includes six dimensions: Appointment keeping (two items); Client-therapist interaction (one item); Communication/Openness (three items); Client's perceived usefulness of treatment (one item); Collaboration with treatment (three items) and Compliance with medication (one item)
|
Week 8 and Week 12
|
Change in Evidence-Based Practice Attitude Scale (EBPAS)
Time Frame: Week 1, week 12
|
Assesses mental health service provider attitudes toward adopting evidence-based practices.
|
Week 1, week 12
|
Service use logs (SUL)
Time Frame: From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
Measures the change in attendance of treatment session by therapists.
|
From the time of the first weekly therapy session until the course of IPT-A treatment is completed, approximately 12 weeks.
|
Termination form (TF)
Time Frame: Week 12
|
Measures the termination of treatment session by therapists
|
Week 12
|
Change in Hamilton Rating Scale for Depression (HRSD)
Time Frame: Baseline, week 1, weeks 4, 8, 12
|
Determines a patient's level of depression before, during, and after treatment.
|
Baseline, week 1, weeks 4, 8, 12
|
Change in Center for Epidemiological Studies-Depression Scale (CES-DC)
Time Frame: Screen, baseline, weeks 4,8,12
|
A 20-item self-report scale designed to measure depressive symptomatology in the general population.
|
Screen, baseline, weeks 4,8,12
|
Change in Suicidal Ideation Questionnaire-Junior (SIQ-Jr)
Time Frame: Baseline, weeks 4,8,12
|
A 15-item self-report measure developed specifically for identifying and assessing current suicidal ideation among young adolescents that requires approximately five to eight minutes to complete.
|
Baseline, weeks 4,8,12
|
Change in Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: Baseline, weeks 4,8,12
|
To assess the severity and lethality of suicidal behaviors and ideations, and can be used to monitor treatment outcomes and establish suicide risk in a variety of research and clinical settings.
|
Baseline, weeks 4,8,12
|
Change in Global Assessment Scale for Children (C-GAS)
Time Frame: Baseline, weeks 4,8,12
|
To reflect the lowest level of functioning for a child or adolescent during a specified time period, or on a hypothetical continuum of health-illness.
|
Baseline, weeks 4,8,12
|
Change in Therapist Satisfaction Questionnaire (TSQ)
Time Frame: Week 1, week 12
|
A 5-point questionnaire filled by therapists to indicate their satisfaction of the therapy (e.g., "the sense of comfort" and "nervousness").
|
Week 1, week 12
|
Demographic Form (DF)
Time Frame: Baseline
|
To measure participants' demographic characteristics
|
Baseline
|
School records (GL)
Time Frame: Baseline
|
To measure youth's school records
|
Baseline
|
Change in School Performance- GPA, Number of Suspensions, and School attendance (SP)
Time Frame: Baseline, weeks 4, 8, 12
|
To measure students' school performance, number of suspensions, and school attendance.
|
Baseline, weeks 4, 8, 12
|
Change in Interpersonal Needs (INQ)
Time Frame: Baseline, weeks 4, 8, 12
|
A 15-item questionnaire to measure changes in students' social connectedness and social competence.
|
Baseline, weeks 4, 8, 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael A Lindsey, PhD, NYU Silver School of Social Work
Publications and helpful links
General Publications
- Gunlicks-Stoessel M, Mufson L, Jekal A, Turner JB. The impact of perceived interpersonal functioning on treatment for adolescent depression: IPT-A versus treatment as usual in school-based health clinics. J Consult Clin Psychol. 2010 Apr;78(2):260-7. doi: 10.1037/a0018935.
- Mufson L, Moreau D, Weissman MM, Wickramaratne P, Martin J, Samoilov A. Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): phase I and II studies. J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):695-705. doi: 10.1097/00004583-199406000-00011.
- Mufson LH, Dorta KP, Olfson M, Weissman MM, Hoagwood K. Effectiveness research: transporting interpersonal psychotherapy for depressed adolescents (IPT-A) from the lab to school-based health clinics. Clin Child Fam Psychol Rev. 2004 Dec;7(4):251-61. doi: 10.1007/s10567-004-6089-6.
- Lindsey MA, Chambers K, Pohle C, Beall P, Lucksted A. Understanding the Behavioral Determinants of Mental Health Service Use by Urban, Under-Resourced Black Youth: Adolescent and Caregiver Perspectives. J Child Fam Stud. 2013 Jan 1;22(1):107-121. doi: 10.1007/s10826-012-9668-z. Epub 2012 Oct 16.
- Lindsey MA, Joe S, Nebbitt V. Family Matters: The Role of Mental Health Stigma and Social Support on Depressive Symptoms and Subsequent Help Seeking Among African American Boys. J Black Psychol. 2010 Nov 1;36(4):458-482. doi: 10.1177/0095798409355796.
- Breland-Noble AM, Bell CC, Burriss A; AAKOMA Project Adult Advisory Board. "Mama just won't accept this": adult perspectives on engaging depressed African American teens in clinical research and treatment. J Clin Psychol Med Settings. 2011 Sep;18(3):225-34. doi: 10.1007/s10880-011-9235-6.
- Lindsey MA, Korr WS, Broitman M, Bone L, Green A, Leaf PJ. Help-seeking behaviors and depression among African American adolescent boys. Soc Work. 2006 Jan;51(1):49-58. doi: 10.1093/sw/51.1.49.
- Lindsey MA, Brown DR, Cunningham M. Boys do(n't) cry: Addressing the unmet mental health needs of African American boys. Am J Orthopsychiatry. 2017;87(4):377-383. doi: 10.1037/ort0000198.
- Ellis ML, Lindsey MA, Barker ED, Boxmeyer CL, Lochman JE. Predictors of engagement in a school-based family preventive intervention for youth experiencing behavioral difficulties. Prev Sci. 2013 Oct;14(5):457-67. doi: 10.1007/s11121-012-0319-9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R34MH119290-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Making Connections Intervention
-
Hopeful AgingBenjamin Rose Institute on AgingNot yet recruiting
-
New York State Psychiatric InstituteTerminatedPsychiatric DiagnosisUnited States
-
Saint Luke's Health SystemWithdrawn
-
University of CalgaryAlzheimer's AssociationRecruitingAlzheimer Disease | Mild Dementia | Moderate DementiaCanada
-
University Hospitals, LeicesterCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Xavier University of Louisiana.Tulane UniversityCompletedProstate CancerUnited States
-
University of WarwickUniversity of BirminghamCompleted
-
FHI 360Center for Population and Reproductive Health, University of IbadanTerminatedHuman Immunodeficiency VirusNigeria
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA)Enrolling by invitationHIV Infections | Substance Use DisordersUnited States